Showing results (631-640 of 716) with videos related to

Sort By:
Pageof 72
JAMA Network Open|May 23, 2022
Association of Alzheimer Disease With Life Expectancy in People With Down SyndromeMaria Florencia Iulita, Diana Garzón Chavez, Maria Klitgaard Christensen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 3, 2025
Generational effects in Down syndrome: Enriched environment enhances functionality without reducing Alzheimer's disease riskLídia Vaqué-Alcázar, Laura Videla, Bessy Benejam, et al.
Brain : a Journal of Neurology|July 13, 2016
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic studyAntoine Leuzy, Konstantinos Chiotis, Steen G Hasselbalch, et al.
Neurology|July 17, 2015
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer diseaseDaniel Alcolea, Pablo Martínez-Lage, Pascual Sánchez-Juan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 11, 2017
Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutationOriol Dols-Icardo, Alberto García-Redondo, Ricardo Rojas-García, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosisLaura Del Hoyo Soriano, Katja Sandkühler, Laura Videla, et al.
The Journal of Infection|March 19, 2026
Persistent T cell phenotypic alterations and early innate immune dysregulation as potential biomarkers of Long COVIDMarina Perez-Mazzali, Francisco Pérez-Cózar, Paloma Cal-Sabater, et al.
Molecular & Cellular Proteomics : MCP|January 5, 2019
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal FluidAlberto Lleó, Raúl Núñez-Llaves, Daniel Alcolea, et al.
Pageof 72